COVID-19 vaccine coverage, safety, and perceptions among patients with diabetes mellitus in China: a cross-sectional study
2023 · Frontiers in Endocrinology · 7 citations
https://doi.org/10.3389/fendo.2023.1172089
J
Jinxing Quan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
691
Citations
12
h-index
14
i10-index
Jinxing Quan is an academic researcher from Guangzhou University of Chinese Medicine. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Cell Adhesion Molecules Research & Atherosclerosis and Cardiovascular Diseases. The author has an h-index of 12, co-authored 57 publications.
ORCID: 0000-0002-4517-3904Papers by this author
worksAssociation of P213S polymorphism of the L-selectin gene with type 2 diabetes and insulin resistance in Chinese population
2012 · Gene · 4 citations
https://doi.org/10.1016/j.gene.2012.07.086
Vitamin D reduces VSMC foam cell formation and protects against AS progression
2025 · Journal of Endocrinology · 1 citations
https://doi.org/10.1530/joe-24-0056
The HYAL1 paradox in cancer: From complex tumor biology to novel therapeutic strategies
2025 · Translational Oncology · 1 citations
https://doi.org/10.1016/j.tranon.2025.102649
Epidemiology of Diabetes in adults in GanSu province of northwest China
2020 · Research Square · 0 citations
https://doi.org/10.21203/rs.3.rs-32037/v2
Perspectives on Stringent Glycemic Control and Weight Loss Among Patients with Type 2 Diabetes in China: A Survey Study
2025 · Diabetes Therapy · 0 citations
https://doi.org/10.1007/s13300-024-01690-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat